🇺🇸 IL-2 (interleukin 2) in United States

11 US adverse-event reports

Safety signals — FAERS

Adverse reaction reports describe suspected side effects. A report does not mean the drug caused the event — co-medications, underlying disease and coincidence all contribute.

Most-reported reactions

  1. Rash — 2 reports (18.18%)
  2. Bradycardia — 1 report (9.09%)
  3. Coronary Artery Disease — 1 report (9.09%)
  4. Deep Vein Thrombosis — 1 report (9.09%)
  5. Fatigue — 1 report (9.09%)
  6. Hypertension — 1 report (9.09%)
  7. Hypoaesthesia — 1 report (9.09%)
  8. Libido Decreased — 1 report (9.09%)
  9. Musculoskeletal Stiffness — 1 report (9.09%)
  10. Nausea — 1 report (9.09%)

Source database →

Other Oncology, Immunology approved in United States

Frequently asked questions

Is IL-2 (interleukin 2) approved in United States?

IL-2 (interleukin 2) does not currently have US marketing authorisation in our dataset.

Who is the marketing authorisation holder for IL-2 (interleukin 2) in United States?

King's College London is the originator. The local marketing authorisation holder may differ — check the official source linked above.